Bristol Myers Squibb

BMS Just Paid to Solve Its Patent Cliff With Someone Else's Pipeline

BMS Just Paid to Solve Its Patent Cliff With Someone Else’s Pipeline

Bristol Myers Squibb's 13-program deal with Hengrui Pharma is the clearest signal yet that Western pharma's next growth decade...

By Moe Alsumidaie
May 12, 2026

Read More